Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

BACKGROUND: The urokinase plasminogen activator receptor is highly expressed and its gene is amplified in about 50% of pancreatic ductal adenocarcinomas; this last feature is associated with worse prognosis. It is unknown whether the level of its soluble form (suPAR) in urine may be a diagnostic-pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sorio, Claudio, Mafficini, Andrea, Furlan, Federico, Barbi, Stefano, Bonora, Antonio, Brocco, Giorgio, Blasi, Francesco, Talamini, Giorgio, Bassi, Claudio, Scarpa, Aldo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2011
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3213238/
https://ncbi.nlm.nih.gov/pubmed/21999221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-448
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi